# Innate Pharma SA: Form 6-K, filed Feb 18, 2025

- Company: [Innate Pharma SA](/companies/ipha.md) (CIK 1598599)
- Form: 6-K
- Filed: 2025-02-18
- Accepted by EDGAR: Feb 18, 2025, 06:16 ET
- Period: 2025-02-17
- Accession: 0001598599-25-000008
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1598599/000159859925000008/a250217_6kincorporated-iphx.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1598599/000159859925000008/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1598599/000159859925000008/a250217_6kincorporated-iphx.htm

Filed Feb 18, 2025.
Source: SEC EDGAR, the filing index for accession 0001598599-25-000008. Last ingested by Listed: Nov 5, 2026, 11:30 ET. No prices; not investment advice.